Hyaluronic Acid Gel-Based Scaffolds as Potential Carrier for Growth Factors: An In Vitro Bioassay on Its Osteogenic Potential.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27916889)

Published in J Clin Med on November 30, 2016

Authors

Masako Fujioka-Kobayashi1,2, Benoit Schaller3, Eizaburo Kobayashi4, Maria Hernandez5, Yufeng Zhang6, Richard J Miron7,8,9

Author Affiliations

1: Department of Cranio-Maxillofacial Surgery, Inselspital, Bern University Hospital, Bern 3010, Switzerland. benoit.schaller@insel.ch.
2: Department of Oral Surgery, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8501, Japan. benoit.schaller@insel.ch.
3: Department of Cranio-Maxillofacial Surgery, Inselspital, Bern University Hospital, Bern 3010, Switzerland. eizabu@ngt.ndu.ac.jp.
4: Department of Cranio-Maxillofacial Surgery, Inselspital, Bern University Hospital, Bern 3010, Switzerland.
5: Department of Periodontology, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. marher@nova.edu.
6: Department of Oral Implantology, University of Wuhan, Wuhan 430079, China. zyf@whu.edu.cn.
7: Department of Periodontology, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. rmiron@nova.edu.
8: Cell Therapy Institute, Center for Collaborative Research, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. rmiron@nova.edu.
9: Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan, MI 48109-1078, USA. rmiron@nova.edu.

Articles cited by this

Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am (2003) 3.36

Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther (2004) 2.55

BMP-9-induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment. J Bone Miner Res (2011) 1.85

Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med (2008) 1.77

BMP and BMP inhibitors in bone. Ann N Y Acad Sci (2006) 1.58

Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med (2008) 1.54

Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery. Spine J (2014) 1.52

Hyaluronic acid in the treatment of TMJ disorders: a systematic review of the literature. Cranio (2010) 1.44

Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology (1995) 1.38

Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem (2000) 1.33

Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol (2005) 1.32

Hyaluronic acid: the scientific and clinical evidence. J Plast Reconstr Aesthet Surg (2007) 1.21

BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells (2013) 1.17

Osteoinduction: a review of old concepts with new standards. J Dent Res (2012) 1.15

Hyaluronic acid based scaffolds for tissue engineering--a review. Carbohydr Polym (2012) 1.11

Bone morphogenetic proteins: facts, challenges, and future perspectives. J Dent Res (2014) 1.11

Osteogenic potential of autogenous bone grafts harvested with four different surgical techniques. J Dent Res (2011) 1.10

Principles and applications of cell delivery systems for periodontal regeneration. Periodontol 2000 (2006) 0.99

Impact of bone harvesting techniques on cell viability and the release of growth factors of autografts. Clin Implant Dent Relat Res (2012) 0.98

BMP signalling in skeletal development, disease and repair. Nat Rev Endocrinol (2016) 0.97

Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ (2016) 0.97

Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations. Clin Oral Implants Res (2008) 0.94

Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor. J Cell Physiol (2009) 0.93

Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: an immunohistochemical study in dogs. Clin Oral Implants Res (2008) 0.92

Comparison of 2 hyaluronic acid drugs for the treatment of temporomandibular joint osteoarthritis. J Oral Maxillofac Surg (2012) 0.89

Hyaluronic acid and wound healing. J Pharm Pharm Sci (2015) 0.89

Osteoblast proliferation and differentiation on a barrier membrane in combination with BMP2 and TGFβ1. Clin Oral Investig (2012) 0.88

Characteristics of high-molecular-weight hyaluronic acid as a brain-derived neurotrophic factor scaffold in periodontal tissue regeneration. Tissue Eng Part A (2011) 0.87

Bone morphogenetic protein 9: a potent modulator of cartilage development in vitro. Growth Factors (2003) 0.86

BMP-2 and bFGF release and in vitro effect on human osteoblasts after adsorption to bone grafts and biomaterials. Clin Oral Implants Res (2012) 0.84

Comparison of the capacity of enamel matrix derivative gel and enamel matrix derivative in liquid formulation to adsorb to bone grafting materials. J Periodontol (2015) 0.82

Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering. Biomaterials (2012) 0.82

Twenty years of enamel matrix derivative: the past, the present and the future. J Clin Periodontol (2016) 0.82

Recombinant Human Bone Morphogenetic Protein 9 (rhBMP9) Induced Osteoblastic Behavior on a Collagen Membrane Compared With rhBMP2. J Periodontol (2016) 0.81

Use of bone morphogenetic proteins in mesenchymal stem cell stimulation of cartilage and bone repair. World J Stem Cells (2016) 0.81

The combination of purified recombinant human platelet-derived growth factor-BB and equine particulate bone graft for periodontal regeneration. J Periodontol (2011) 0.81

Gene therapy for bone engineering. Front Bioeng Biotechnol (2015) 0.81

In vitro studies on biocompatibility of hyaluronic acid esters. Biomaterials (1991) 0.80

Osteogenic potential of rhBMP9 combined with a bovine-derived natural bone mineral scaffold compared to rhBMP2. Clin Oral Implants Res (2016) 0.79

Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel. J Control Release (2015) 0.79

Investigating the importance of flow when utilizing hyaluronan scaffolds for tissue engineering. J Tissue Eng Regen Med (2010) 0.79

In vivo experimental study on bone regeneration in critical bone defects using PIB nanogels/boron-containing mesoporous bioactive glass composite scaffold. Int J Nanomedicine (2015) 0.78

Effect of hyaluronic acid in bone formation and its applications in dentistry. J Biomed Mater Res A (2016) 0.78

Modulation of biomechanical properties of hyaluronic acid hydrogels by crosslinking agents. J Biomed Mater Res A (2015) 0.78

Enamel matrix derivative in combination with bone grafts: A review of the literature. Quintessence Int (2014) 0.77

Hyaluronan and cardiac regeneration. J Biomed Sci (2014) 0.77

Osteogenic signaling on silk-based matrices. Biomaterials (2016) 0.76

Addition of a Synthetically Fabricated Osteoinductive Biphasic Calcium Phosphate Bone Graft to BMP2 Improves New Bone Formation. Clin Implant Dent Relat Res (2015) 0.76

Mesenchymal stem cells and alginate microcarriers for craniofacial bone tissue engineering: A review. J Biomed Mater Res A (2016) 0.76